Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XVI.j

Major/massive hemoptysis

Can be fatal from blood loss, or clotting in the central airway causing acute airway compromise and respiratory failure

Publications

Goto K, Endo M, Kusumoto M, Yamamoto N, Ohe Y, Shimizu A, Fukuoka M

Bevacizumab for non-small-cell lung cancer: A nested case control study of risk factors for hemoptysis.

Cancer science 2016 Dec;107;1837-1842 — 2016 Dec — 1837-1842

Okamoto K, Okamoto I, Miyazaki M, Tanaka K, Kaneda H, Nakagawa K

Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancer.

Investigational new drugs 2013 Oct;31;1364-6 — 2013 Oct — 1364-6

Hapani S, Sher A, Chu D, Wu S

Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis.

Oncology 2010;79;27-38 — 2010 — 27-38

Herbst RS, O'Neill VJ, Fehrenbacher L, Belani CP, Bonomi PD, Hart L, Melnyk O, Ramies D, Lin M, Sandler A

Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 20;25;4743-50 — 2007 Oct 20 — 4743-50

Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

The New England journal of medicine 2006 Dec 14;355;2542-50 — 2006 Dec 14 — 2542-50

Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, Langer CJ, DeVore RF, Gaudreault J, Damico LA, Holmgren E, Kabbinavar F

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Jun 01;22;2184-91 — 2004 Jun 01 — 2184-91